What You Should Know:
– The U.S. Department of Health and Human Services (HHS) has announced a new regulatory reform that will give doctors and patients real-time access to prescription drug information.
– The rule, which…
Continue Reading
In this powerful episode of Digital Health Interviews, we sit down with Dr. Jesse Ehrenfeld, 178th President of the American Medical Association, a physician, veteran, and a leading voice for equity and innovation in…
Continue Reading
What You Should Know:
– EVERSANA and Waltz Health have announced a merger valued at $6B to form a unified healthcare platform that will redefine pharmaceutical commercialization and patient access.
– The merger combines Waltz Health’s…
Continue Reading
This systematic review examines the cost-effectiveness, utility, and budget impact of clinical artificial intelligence (AI) interventions across diverse healthcare settings. Nineteen studies spanning oncology, cardiology, ophthalmology, and infectious diseases demonstrate that AI improves diagnostic…
Continue Reading
Jay Adams, Executive Vice President of Altera Sunrise
Across the country, rural and community hospitals are being offered a familiar pitch: access to a premium electronic health record (EHR) platform at a fraction of the…
Continue Reading
A retrospective, registry-based cost-minimization analysis assessing whether initiating minor acute primary care episodes via a digital-first pathway reduces costs compared to traditional care in a Finnish setting. Of 637,923 encounters, 64,969 eligible episodes were…
Continue Reading
The Crisis of Hospital Readmissions
Hospital readmissions represent one of healthcare’s most pressing challenges, with devastating consequences for both patients and healthcare systems. The statistics paint a sobering picture: nearly 1 in 5 Medicare patients…
Next-generation sequencing-based tests have advanced the field of medical diagnostics, but their novelty and cost can lead to uncertainty in clinical deployment. The Heme-STAMP is one such assay that tracks mutations in genes implicated…
Continue Reading
Healthcare Industry Faces Tariff Challenges
As the Trump administration advances comprehensive tariff policies designed to boost domestic manufacturing, healthcare systems across the United States are implementing robust strategies to shield patients from potential disruptions and…
Thomas Kluz, Managing Director at Niterra Ventures
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.
Drug development has long been marked…
Continue Reading
